Search

Technology sneak peek from Ascenion: Get ready for this year’s BioVaria on 27–28 April 2026

Ascenion is looking forward to its annual reunion with industry decision makers, venture capitalists, academic inventors and entrepreneurs. Ten of around 60 projects to be featured originate from Ascenion’s academic partners. 

This year’s hot topics include novel approaches in the fields of oncology, pharmaceutical research and immunology. In addition, exciting projects relating to infectious diseases and neurological disorders will be presented. Ascenion’s partners are contributing a total of ten projects:

A1 ASO-Based mRNA Silencing Technology for Phage
Helmholtz Institute for RNA-based Infection Research (HIRI)

A2 Novel CARs for the Treatment of Multiple Sclerosis and Alzheimer´s Disease
Hannover Medical School

A3 AI-based Method and Tool (DeepNeo) for Intravascular Optical Coherence Tomography Image Analysis of Coronary Artery Neointimal Tissue
Helmholtz Munich

A4 ICR-001: First-in-class dual action oral therapy for secondary stroke prevention
Charité – Universitätsmedizin Berlin

A5 TReAT - A Novel Tacrolimus-Resistant Antiviral T-Cell-Therapy
Charité – Universitätsmedizin Berlin

A6 CRISPR-Cas9 Mediated Proteinase 3 Autoantigen Deletion as a Treatment Strategy for ANCA-Associated Vasculitis
Max Delbrueck Center

A7 FAP-Targeted Dual Imaging for Guided Cancer Surgery
Medical University of Innsbruck

A8 Inhibition of TGFβ1-induced Long Non-Coding RNAs Prevents Cardiac Fibrosis
Hannover Medical School

SPIN-OFF Silicone oil-free syringe adapter - “PURINGE”
Charité – Universitätsmedizin Berlin

SPIN-OFF Bionebula: Bioluminescence Imaging Solutions
Helmholtz Munich

A further programme highlight is BioVaria’s dedicated Startup Pitch & Partner programme. It offers ten start-ups selected by a renowned jury the opportunity to pitch in front of top-class venture capitalists and make important contacts during speed dating. Industry representatives and investors can get to know start-ups at different stages of development.

The Early-Stage Innovation stream has also become an established part of the programme due to the positive response in previous years. Researchers will present their promising early-stage projects, including those funded by GO-Bio initial, to an audience of industry representatives and VCs for the first time and gather valuable feedback.

For 25 years, Ascenion has been making a difference in society through innovations developed by its partner institutes. We would like to look back on this journey with all participants and guests during a short anniversary programme at BioVaria, and raise a glass to the past 25 years and the next 25 in the relaxed atmosphere of the Augustiner beer garden.

Don’t miss your chance, join in!